Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2026-05-08 @ 8:22 PM
Study NCT ID:
NCT01581203
Status:
COMPLETED
Last Update Posted:
2015-10-09
First Post:
2012-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AI447-028
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None